PathoAiD®-Thyroid Dx

PathoAiD®-Thyroid Dx aims to address the significant issue of diagnostic
uncertainties which leads to thyroid cancer misdiagnosis, causing both
untreated cases and unnecessary surgeries. Our AI-driven product
uniquely interprets core needle biopsy images, enhancing diagnostic
accuracy and reducing financial burdens for patients.

Ready for Nomination Season?

Complete the form below to download the 2027 Nomination Guide.

A Founders Guide to Modern Innovation
The Future of the Grid – Panel Discussion 2024 Edison Awards
Edison Award-Winning Brain Technology Featured in U.S. News & World Report